TRIM63 and glioblastoma: Altogether, our modeling data using patient-relevant oncogene combination in tp53 loss-of-function background demonstrates an important role for inflammation in glioblastoma initiation and relapse including inhibitory roles for Irf-dependent signaling pathways, which in part may be attributed to anti-tumoral phagocyte activity within the TME.